Pharmaceutical Manufacturing and Packaging

The contract requires the manufacture and packaging of Bismuth Subsalicylate Tablets in sealed unit containers that meet stringent regulatory and military standards, including FDA requirements, cGMP guidelines, and MIL-STD-2073-1E along with MPPWN00001 for military packaging. All production must ensure product integrity, sterility, and compliance with federal pharmaceutical and defense logistics protocols, with performance specifically tied to Fort Campbell, Tennessee, under the oversight of the Department of Defense’s Medical Supply Chain Pharm FSA. The solicitation is categorized as a subcontract under NAICS code 325412 for pharmaceutical preparation manufacturing, with a response deadline of July 27, 2026, and a posting date of July 21, 2026, indicating a short turnaround for potential contractors to submit proposals. There is no set-aside designation specified, and the contract is open to qualified subcontractors capable of meeting the high-volume, high-compliance demands of military pharmaceutical supply chains.